Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug.

Abstract

Organisms lacking external defense mechanisms have developed chemical defense strategies, particularly through the production of secondary metabolites with antibiotic or repellent effects. Secondary metabolites from marine organisms have proven to be an exceptionally rich source of small molecules with pharmacological activities potentially beneficial to human health. (+)-Aeroplysinin-1 is a secondary metabolite isolated from marine sponges with a wide spectrum of bio-activities. (+)-Aeroplysinin-1 has potent antibiotic effects on Gram-positive bacteria and several dinoflagellate microalgae causing toxic blooms. In preclinical studies, (+)-aeroplysinin-1 has been shown to have promising anti-inflammatory, anti-angiogenic and anti-tumor effects. Due to its versatility, (+)-aeroplysinin-1 might have a pharmaceutical interest for the treatment of different pathologies.

• Authors: Javier A García-Vilas, Beatriz Martínez-Poveda, Ana R Quesada, Miguel Ángel Medina
• Journal: Marine drugs (Mar Drugs) Vol. 14 Issue 1 Pg. 1 (Dec 22 2015) ISSN: 1660-3397 [Electronic] Switzerland
• PMID: 26703630 (Publication Type: Journal Article, Review)

Chemical References

• Acetonitriles
• Anti-Bacterial Agents
• Cyclohexenes
• aeroplysinin I

Topics

• Acetonitriles (chemistry, pharmacology)
• Animals
• Anti-Bacterial Agents (chemistry, pharmacology)
• Cyclohexenes (chemistry, pharmacology)
• Gram-Positive Bacteria (drug effects)
• Humans
• Porifera
• Seawater